Published in Diabetes Metab on November 01, 2004
Prevention of exercise-associated dysglycemia: a case study-based approach. Diabetes Spectr (2015) 0.84
Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab (2015) 0.83
Oxidative stress in patients with type 1 diabetes mellitus: is it affected by a single bout of prolonged exercise? PLoS One (2014) 0.79
Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances. PLoS One (2015) 0.78
Diabetes in sports. Sports Health (2010) 0.75
Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review. Int J Endocrinol Metab (2016) 0.75
Metabolic Effects of Glucose-Fructose Co-Ingestion Compared to Glucose Alone during Exercise in Type 1 Diabetes. Nutrients (2017) 0.75
Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes. PLoS One (2017) 0.75
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet (1998) 6.17
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.96
Open questions about metabolically normal obesity. Int J Obes (Lond) (2010) 1.83
Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism (1982) 1.79
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes (1987) 1.76
Multidisciplinary approach to obesity treatment. Diabetes Obes Metab (2003) 1.47
Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients. Diabetes Metab (2003) 1.41
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
Pathways from obesity to diabetes. Int J Obes Relat Metab Disord (2002) 1.36
Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.24
Glucose-induced thermogenesis in nondiabetic and diabetic obese subjects. Diabetes (1982) 1.23
Gait characteristics of diabetic patients: a systematic review. Diabetes Metab Res Rev (2008) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol (1996) 1.10
Randomised controlled trial of a guided self-help treatment on the Internet for binge eating disorder. Behav Res Ther (2011) 1.09
The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia (2009) 1.08
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05
Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab (1986) 1.02
Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab (2000) 1.01
Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism (1990) 1.01
Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab (2005) 0.99
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism (1987) 0.99
Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia (1987) 0.98
Factors influencing energy intake and body weight loss after gastric bypass. Eur J Clin Nutr (2002) 0.98
Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes (Lond) (2011) 0.98
Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab (1986) 0.96
The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab (2000) 0.95
Evaluation of a guided internet self-treatment programme for bulimia nervosa in several European countries. Eur Eat Disord Rev (2010) 0.95
Regulation of glucose storage in obesity and diabetes: metabolic aspects. Diabetes Metab Rev (1988) 0.95
Decreased glucose-induced thermogenesis after weight loss in obese subjects: a predisposing factor for relapse of obesity? Am J Clin Nutr (1984) 0.95
Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest (1984) 0.94
The impact of callosities on the magnitude and duration of plantar pressure in patients with diabetes mellitus. A callus may cause 18,600 kilograms of excess plantar pressure per day. Diabetes Metab (2002) 0.93
Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia (2007) 0.92
Effect of weight loss on glucose disposal in obese and obese diabetic patients. Int J Obes (1985) 0.92
Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia (2007) 0.91
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). Proc Nutr Soc (1997) 0.90
Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr (1985) 0.90
Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. Lancet (1998) 0.90
Reversible oligomerization and denaturation of the chaperonin GroES. Biochemistry (1996) 0.89
Renal transplantation in a C-ANCA(+) patient with Behcet disease and rapidly progressive glomerulonephritis. Clin Nephrol (2004) 0.89
Investigation of standing balance in diabetic patients with and without peripheral neuropathy using accelerometers. Clin Biomech (Bristol, Avon) (2009) 0.89
Study on lipid metabolism in obesity diabetes. Metabolism (1984) 0.88
Impact of body fat mass extent on cardiac autonomic alterations in women. Eur J Clin Invest (2009) 0.88
Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance. Diabet Med (1999) 0.88
Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal. Diabete Metab (1992) 0.87
An exercise intervention to improve diabetic patients' gait in a real-life environment. Gait Posture (2010) 0.86
Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease. Diabet Med (2005) 0.86
Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study. Eur J Clin Invest (2009) 0.85
Obesity: a complex growing challenge. Exp Clin Endocrinol Diabetes (2009) 0.85
Regulation of nutrient metabolism and energy expenditure. Metabolism (1995) 0.85
Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes Surg (2008) 0.85
Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects. Int J Obes (1986) 0.84
Conditions for nucleotide-dependent GroES-GroEL interactions. GroEL14(groES7)2 is favored by an asymmetric distribution of nucleotides. J Biol Chem (1997) 0.84
Type I diabetes and marathon running. Diabetes Care (1993) 0.84
[Rimonabant improves cardiometabolic risk profile in obese or overweight subjects: overview of RIO studies]. Rev Med Suisse (2006) 0.84
Impact of lifestyle intervention on body weight and the metabolic syndrome in home-care providers. Diabetes Metab (2012) 0.84
Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study. J Diabetes Complications (2012) 0.83
Isolation, amino acid analyses and refolding of subunits of pig heart succinyl-CoA synthetase. Biochem J (1988) 0.83
Clinical factors associated with gait alterations in diabetic patients. Diabet Med (2009) 0.83
Physical activity and fat-free and fat mass by bioelectrical impedance in 3853 adults. Med Sci Sports Exerc (2001) 0.83
Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr (2000) 0.83
Efficacy of rimonabant in obese patients with binge eating disorder. Exp Clin Endocrinol Diabetes (2012) 0.82
Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus. Diabetes Metab (2008) 0.82
Cognitive distortions in obese patients with or without eating disorders. Eat Weight Disord (2006) 0.82
Glycemia-lowering effect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis. Am J Physiol (1998) 0.82
High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab (1987) 0.82
Incidental pituitary macroadenoma: a population-based study. Am J Med Sci (1997) 0.82
Chemical modification of tryptophan residues in Escherichia coli succinyl-CoA synthetase. Effect on structure and enzyme activity. Biochemistry (1986) 0.82
Reliability of diabetic patients' gait parameters in a challenging environment. Gait Posture (2008) 0.82
[About 10 cases of Launois-Bensaude disease]. Ann Chir Plast Esthet (2008) 0.82
Comparison of metabolic effects of white beans processed into two different physical forms. Diabetes Care (1986) 0.81
[Understanding obesity in Africa: the effect of [economic] development and [mental] concepts]. Rev Med Suisse (2014) 0.81
Biofeedback for foot offloading in diabetic patients with peripheral neuropathy. Diabet Med (2010) 0.81
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas (1999) 0.81
Evaluation of a psycho-educational nutritional program in diabetic patients. Patient Educ Couns (2001) 0.81
Contrast sensitivity in obese dyslipidemic patients with insulin resistance. Arch Ophthalmol (1998) 0.81
High hydrostatic pressure can probe the effects of functionally related ligands on the quaternary structures of the chaperonins GroEL and GroES. J Biol Chem (2000) 0.81
Divalent cations can induce the exposure of GroEL hydrophobic surfaces and strengthen GroEL hydrophobic binding interactions. Novel effects of Zn2+ GroEL interactions. J Biol Chem (1998) 0.81
Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids. Horm Metab Res (2010) 0.81
New interdisciplinary cognitive-behavioural-nutritional approach to obesity treatment: a 5-year follow-up study. Eat Weight Disord (2004) 0.80
Patient education in Switzerland: from diabetes to chronic diseases. Patient Educ Couns (2001) 0.80
Intrinsic fluorescence studies of the chaperonin GroEL containing single Tyr --> Trp replacements reveal ligand-induced conformational changes. J Biol Chem (1996) 0.80
Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients. Diabetes Metab (2002) 0.80
Effects of varied cardioplegic perfusion pressure on myocardial preservation with critical coronary stenosis. Ann Thorac Surg (1985) 0.79
Stimulation of thermogenesis in men after combined glucose-long-chain triglyceride infusion. Am J Clin Nutr (1983) 0.79
Relationship between hyperinsulinemia and angiographically defined coronary atherosclerosis in non-diabetic men. Diabetes Metab (2002) 0.79
Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland. Int J Obes (Lond) (2005) 0.79
GroES in the asymmetric GroEL14-GroES7 complex exchanges via an associative mechanism. Proc Natl Acad Sci U S A (1999) 0.79
Lipoprotein distribution and composition in obesity: their association with central adiposity. Int J Obes Relat Metab Disord (1997) 0.79
Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Diabetes Metab (2001) 0.78
Effect of trestatin, a new inhibitor of pancreatic alpha-amylase, on starch metabolism in man. Int J Obes (1986) 0.78
Relationship between sympathetic reactivity and body weight loss in morbidly obese subjects. Int J Obes Relat Metab Disord (2004) 0.78
The metabolic consequences of long-term human obesity. Int J Obes (1988) 0.77
[Impulsivity--is one of the factors responsible for obesity?]. Rev Med Suisse (2007) 0.77
Decreased thermogenic response to an oral glucose load in older subjects. J Am Geriatr Soc (1983) 0.77
Cognitive-behavioral therapy with simultaneous nutritional and physical activity education in obese patients with binge eating disorder. Eat Weight Disord (2004) 0.77
Double-phase parathyroid 99mTc-Sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function. Nucl Med Commun (2003) 0.77